The superiority of the CPS method in this study was mainly determined by the reallocation of the TPS−/CPS+ subgroup away from the TPS-negative subgroup, suggesting that this TPS−/CPS+ subgroup may have a comparable sensitivity to ICI as the TPS-positive subgroup through the PD-L1 blockade on tumor and inflammatory immune cells. Here, CD274 is linked to neoplasm.